These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12945527)

  • 21. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group.
    Dubé MP; Stein JH; Aberg JA; Fichtenbaum CJ; Gerber JG; Tashima KT; Henry WK; Currier JS; Sprecher D; Glesby MJ; ;
    Clin Infect Dis; 2003 Sep; 37(5):613-27. PubMed ID: 12942391
    [No Abstract]   [Full Text] [Related]  

  • 22. [HIV infection: emerging issues and new challenges].
    Calza L; Manfredi R; Chiodo F
    Recenti Prog Med; 2006 Dec; 97(12):771-80. PubMed ID: 17252736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects.
    Bergersen BM; Sandvik L; Bruun JN; Tonstad S
    Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):625-30. PubMed ID: 15322938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiretroviral therapy in HIV-infected children: the metabolic cost of improved survival.
    Leonard EG; McComsey GA
    Infect Dis Clin North Am; 2005 Sep; 19(3):713-29. PubMed ID: 16102657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
    Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S
    Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin Resistance and the cardiometabolic syndrome in HIV infection.
    Bevilacqua M; Dominguez LJ; Barbagallo M
    J Cardiometab Syndr; 2009; 4(1):40-3. PubMed ID: 19245515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New therapy strategies focusing on long term. Drugs' impact on heart is debated.
    AIDS Alert; 2003 Apr; 18(4):45-7. PubMed ID: 12710403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Coronary heart disease associated with the use of highly active antiretroviral therapy (HAART). A case report and review].
    Neumann T; Kondratieva J; Eggebrecht H; Wieneke H; Esser S; Bartel T; Erbel R
    Herz; 2005 Sep; 30(6):504-9. PubMed ID: 16170681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peyronie's disease in men with HIV responding to highly active antiretroviral therapy.
    Rogers GD; French MA
    HIV Med; 2004 May; 5(3):185-6. PubMed ID: 15139986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hospitalizations of pregnant HIV-infected women in the United States in the era of highly active antiretroviral therapy (HAART).
    Bansil P; Jamieson DJ; Posner SF; Kourtis AP
    J Womens Health (Larchmt); 2007 Mar; 16(2):159-62. PubMed ID: 17388731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection.
    Butt AA; Fultz SL; Kwoh CK; Kelley D; Skanderson M; Justice AC
    Hepatology; 2004 Jul; 40(1):115-9. PubMed ID: 15239093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Also consider cardiovascular risk. Every HIV patient "his" HAART].
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():58-60. PubMed ID: 19031565
    [No Abstract]   [Full Text] [Related]  

  • 33. Editorial comment: Coronary artery disease and HIV infection--should we be concerned?
    Glesby MJ
    AIDS Read; 2001 May; 11(5):266. PubMed ID: 11592242
    [No Abstract]   [Full Text] [Related]  

  • 34. Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients.
    Iloeje UH; Yuan Y; L'italien G; Mauskopf J; Holmberg SD; Moorman AC; Wood KC; Moore RD
    HIV Med; 2005 Jan; 6(1):37-44. PubMed ID: 15670251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular disease prevention and treatment in patients with human immunodeficiency virus.
    Magen E; Elbirt D; Sthoeger Z
    Isr Med Assoc J; 2005 Apr; 7(4):252-6. PubMed ID: 15847207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-terminal pro-B-type natriuretic peptide (NT-proBNP) in HIV-1 infected individuals on HAART.
    Berg T; Zdunek D; Stalke J; Dupke S; Baumgarten A; Carganico A; Hess G
    Eur J Med Res; 2007 Apr; 12(4):152-60. PubMed ID: 17509959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of metabolic drugs and fish oil in HIV-positive patients with metabolic complications and associations with dyslipidaemia and treatment targets.
    Normén L; Yip B; Montaner J; Harris M; Frohlich J; Bondy G; Hogg RS
    HIV Med; 2007 Sep; 8(6):346-56. PubMed ID: 17661842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV and the menopause.
    Fan MD; Maslow BS; Santoro N; Schoenbaum E
    Menopause Int; 2008 Dec; 14(4):163-8. PubMed ID: 19037065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distal sensory polyneuropathy in HIV-positive patients in the HAART era: an entity underestimated by clinical examination.
    Skopelitis EE; Kokotis PI; Kontos AN; Panayiotakopoulos GD; Konstantinou K; Kordossis T; Karandreas N
    Int J STD AIDS; 2006 Jul; 17(7):467-72. PubMed ID: 16820077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.